Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
Authors
Keywords
-
Journal
LEUKEMIA
Volume 26, Issue 6, Pages 1348-1355
Publisher
Springer Nature
Online
2012-01-06
DOI
10.1038/leu.2011.362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Post-translational modifications regulate signalling by Ror1
- (2011) M. Kaucká et al. Acta Physiologica
- Nutlin-3 Downregulates the Expression of the Oncogene TCL1 in Primary B Chronic Lymphocytic Leukemic Cells
- (2011) R. Voltan et al. CLINICAL CANCER RESEARCH
- Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)
- (2011) Sabrina Uhrmacher et al. LEUKEMIA RESEARCH
- Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
- (2011) Jiahui Yang et al. PLoS One
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro
- (2010) Russell J. Collins et al. BRITISH JOURNAL OF HAEMATOLOGY
- Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
- (2010) Aniruddha Choudhury et al. BRITISH JOURNAL OF HAEMATOLOGY
- ROR1 expression is not a unique marker of CLL
- (2010) Gábor Barna et al. HEMATOLOGICAL ONCOLOGY
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
- (2010) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia
- (2010) Lynda B Bennett et al. Epigenomics
- Wnt5a regulates distinct signalling pathways by binding to Frizzled2
- (2009) Akira Sato et al. EMBO JOURNAL
- Cetuximab and panitumumab: are they interchangeable?
- (2009) Richard Kim LANCET ONCOLOGY
- Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia
- (2009) A Österborg et al. LEUKEMIA
- Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
- (2009) Doris R. Siwak et al. Journal of Oncology
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia
- (2008) S. Baskar et al. CLINICAL CANCER RESEARCH
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
- (2008) Amir H. DaneshManesh et al. INTERNATIONAL JOURNAL OF CANCER
- Carboxypeptidase Z (CPZ) Links Thyroid Hormone and Wnt Signaling Pathways in Growth Plate Chondrocytes
- (2008) Lai Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase
- (2008) Yan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
- (2008) T. Fukuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ror receptor tyrosine kinases: orphans no more
- (2008) Jennifer L. Green et al. TRENDS IN CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now